Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
The purpose of this study is to test the safety and effectiveness of Exablate PTT (pallidothalamic tract) lesioning as a staged (2 procedures 6 months apart), bilateral (both sides of your brain) procedure to treat the motor complications in patients with idiopathic Parkinson's Disease (PD). The results of this study will help us determine whether ablation of PTT with focused ultrasound is a safe procedure in patients with idiopathic PD.
Open to men and women, age 30 years and older with a diagnosis of Parkinson's Disease (PD) as confirmed by a movement disorder neurologist.
Subjects must be on a stable dose of all PD medications for 30 days prior to screening visit PD assessments as determined by medical records
Detailed eligibility will be reviewed when you contact the study team.
Upper East Side - Manhattan
Open to Enrollment
